Dosing & Administration
Adult Dose
Inhalation solution: 3 mL (2.5 mg/0.5 mg) via nebulizer QID. Respimat: 1 inhalation QID.
Pediatric Dose
1 nebulizer treatment every 20 mins x 3 for acute asthma exacerbation.
Renal Adjustment
No adjustment necessary.
Hepatic Adjustment
No adjustment necessary.
Safety & Special Populations
Pregnancy Category
C
Lactation Safety
Compatible.
Contraindications & Adverse Effects
Contraindications
- Hypersensitivity to atropine derivatives
- Peanut/soy allergy (older MDI formulations only)
Common Adverse Effects
- Dry mouth
- Tachycardia
- Urinary retention
- Glaucoma exacerbation (if mask leaks into eyes)